Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

por Peral, Carmen, Sánchez-Ballester, Francisco, García-Mediero, José M, Ramos, Jaime, Rejas, Javier
Publicado 2016

Dose and aging effect on patients reported treatment benefit switching from the first overactive bladder therapy with tolterodine ER to fesoterodine: post-hoc analysis from an obse...

por Castro-Diaz, David, Miranda, Pilar, Sanchez-Ballester, Francisco, Lizarraga, Isabel, Arumí, Daniel, Rejas, Javier
Publicado 2012